Febrile neutropenia - an approach to outpatient therapy - prospective validation of the MASCC score for low-risk patients

被引：0
|
作者：
Gomes, FMR [1 ]
Marques, AMS [1 ]
Costa, FAO [1 ]
机构：
[1] Portuguse Inst Oncol, Lisbon, Portugal
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：294 / 294
页数：1
相关论文
共 50 条
  • [41] MANAGEMENT OF LOW RISK FEBRILE NEUTROPENIA IN SOLID TUMOR PATIENTS IN THE OUTPATIENT SETTING
    Rodgers, Georgina
    Tackitt, Helen
    Kunapareddy, Girish
    Stevenson, James
    Colella, Frank
    [J]. ONCOLOGY NURSING FORUM, 2018, 45 (02)
  • [42] No Place Like Home? Outpatient Management of Patients With Febrile Neutropenia and Low Risk
    Freifeld, Alison G.
    Sepkowitz, Kent A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (30) : 3952 - 3954
  • [43] Effect of serum uric acid (ua) level and MASCC risk score on febrile neutropenia mortality
    Sutcuoglu, O.
    Akdogan, O.
    Inci, B. Kurt
    Gurler, F.
    Yildirim, N. Ozdemir
    Yazici, O.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1055 - S1055
  • [44] Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
    Marianne Paesmans
    Jean Klastersky
    Johan Maertens
    Aspasia Georgala
    Frédérique Muanza
    Mickael Aoun
    Augustin Ferrant
    Bernardo Rapoport
    Ken Rolston
    Lieveke Ameye
    [J]. Supportive Care in Cancer, 2011, 19 : 1001 - 1008
  • [45] The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients
    Klastersky, Jean
    Paesmans, Marianne
    [J]. SUPPORTIVE CARE IN CANCER, 2013, 21 (05) : 1487 - 1495
  • [46] Single-Agent, Broad-Spectrum Fluoroquinolones for the Outpatient Treatment of Low-Risk Febrile Neutropenia
    Cooper, Maryann R.
    Durand, Cheryl R.
    Beaulac, Matthew T.
    Steinberg, Michael
    [J]. ANNALS OF PHARMACOTHERAPY, 2011, 45 (09) : 1094 - 1102
  • [47] Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?
    Paesmans, Marianne
    Klastersky, Jean
    Maertens, Johan
    Georgala, Aspasia
    Muanza, Frederique
    Aoun, Mickael
    Ferrant, Augustin
    Rapoport, Bernardo
    Rolston, Ken
    Ameye, Lieveke
    [J]. SUPPORTIVE CARE IN CANCER, 2011, 19 (07) : 1001 - 1008
  • [48] The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients
    Jean Klastersky
    Marianne Paesmans
    [J]. Supportive Care in Cancer, 2013, 21 : 1487 - 1495
  • [49] FEASIBILITY OF OUTPATIENT MANAGEMENT OF FEVER IN CANCER-PATIENTS WITH LOW-RISK NEUTROPENIA - RESULTS OF A PROSPECTIVE RANDOMIZED TRIAL
    MALIK, IA
    KHAN, WA
    KARIM, M
    AZIZ, Z
    KHAN, MA
    [J]. AMERICAN JOURNAL OF MEDICINE, 1995, 98 (03): : 224 - 231
  • [50] Treating low-risk febrile neutropenia: Jenny's story
    Phillips, R.
    Skinner, R.
    Chisholm, J. C.
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 2007, 92 (01) : 7 - 8
12345